Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapies for COVID-19
NCT04459702Phase 2Withdrawn
- Sponsor
- ProgenaBiome
- Start
- Jul 2020
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine, azithromycin, lopinavir, ritonavir in coronavirus disease 2019 (COVID-19), sponsored by ProgenaBiome. Planned start Jul 2020; status: withdrawn.
02
Drugs
hydroxychloroquineazithromycinlopinavirritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04459702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04459702.